What Researchers Did
Researchers examined changes in tumour cell growth indicators (labeling index and growth fraction) in biopsy samples from patients with oropharyngeal cancer undergoing radiation therapy.
What They Found
The study found that a significant decrease in these indicators (labeling index and growth fraction) during radiotherapy was a better predictor of tumour response than their initial levels. A sharp drop or decrease to zero indicated high tumour radiosensitivity and a favorable prognosis, allowing for continued radical radiotherapy. Conversely, an increase in these indicators midway through treatment suggested the tumour was resistant to radiation.
What This Means for Canadian Patients
This study suggests that monitoring specific tumour growth indicators during radiation therapy for oropharyngeal cancer could help doctors predict how well a patient will respond to treatment. This information might help guide treatment decisions, such as continuing with radiation or considering surgery or combined therapies for tumours that show resistance.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This older study's abstract does not provide details on patient numbers, specific treatment protocols, or long-term patient outcomes.